Get the Stockscreener App
7.56
0.66%
-0.05
Exagen Inc stock is traded at $7.56, with a volume of 454.39K.
It is down -0.66% in the last 24 hours and down -36.79% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$7.61
Open:
$7.6
24h Volume:
454.39K
Relative Volume:
1.48
Market Cap:
$171.33M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-8.0426
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-10.74%
1M Performance:
-36.79%
6M Performance:
+14.55%
1Y Performance:
+84.39%
1-Day Range:
$7.45
$7.645
1-Week Range:
$7.45
$8.55
52-Week Range:
$2.76
$12.23
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.56 | 172.47M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Is Exagen Inc. (E08A) stock protected from inflationWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Why Exagen Inc. (E08A) stock stays resilient2025 Price Momentum & Target Return Focused Stock Picks - newser.com
Is Exagen Inc. (E08A) stock good for wealth creationVolume Spike & Risk Managed Trade Strategies - newser.com
Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India
The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st
Head-To-Head Analysis: EssilorLuxottica (OTCMKTS:ESLOY) and Exagen (NASDAQ:XGN) - Defense World
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - Nasdaq
Is Exagen Inc. stock a defensive play in 2025July 2025 Summary & Reliable Volume Spike Alerts - newser.com
How higher bond yields impact Exagen Inc. (E08A) stockPortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
Is Exagen Inc. stock attractive for long term wealth buildingWeekly Risk Report & Consistent Profit Alerts - newser.com
How to monitor Exagen Inc. with trend dashboardsGold Moves & High Yield Equity Trading Tips - newser.com
Exagen Inc. stock retracement – recovery analysisMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):